DHR

DHR’s Historical Earnings Track Record and Price Drift

DHR has beaten the official consensus in 7 of its last 8 reported quarters, a 100% beat rate over that span, with an average earnings surprise of 7.3%. The actual beats have been substantial: the most recent report on 2026-07-21 showed EPS of $1.94 versus a $1.85 estimate, a 4.9% surprise; the 2025-10-21 quarter delivered $1.89 against $1.72, a 9.9% surprise. Yet the average 5-day price move after earnings across those same eight quarters is -0.2%, classified as “flat.” That single number is important: it tells you that DHR’s underlying results have consistently exceeded the published estimate without fueling a reliably positive short-term stock reaction.

Looking at the last four quarters makes this pattern even clearer. DHR beat every report, but the next-day moves were 0.07% on 2026-07-21, -5.4% on 2026-04-21, -2.19% on 2026-01-28, and -1.21% on 2025-10-21. Only the July 2026 report escaped a negative next-day response, and it was essentially unchanged. The post-earnings drift also shows the same story: a strong +11.19% five-day drift followed the July report, but the prior three quarters produced five-day drifts of -8.0%, -2.23%, and -1.75%. The math averages out to nearly zero, which means beating estimates has not, by itself, produced a predictable upward price move.

How Options Markets May Price the Oct. 20 Report

Because DHR’s next earnings release is scheduled for 2026-10-20 before the open, with a consensus EPS estimate of $1.96, options markets typically expand implied volatility ahead of the event. A high beat rate and a 7.3% average surprise can encourage demand for call structures, but the flat average post-earnings drift warns that realized directional moves have been limited. That combination can make long premium expensive relative to what the stock has actually done: even when DHR beats, the next-day and five-day price changes in the last four quarters have often been smaller than the implied move priced into at-the-money straddles.

After the announcement, the same dynamic usually produces a sharp implied-volatility contraction, especially if the report lands close to the unofficial consensus. Traders should watch whether the market’s real expectation sits above or below the published $1.96 estimate and whether option skew is tilted toward calls or puts. A lopsided options flow into calls can exaggerate the post-event volatility collapse if DHR’s beat does not trigger a large move, while elevated put flow may signal participants are hedging against another negative reaction similar to April or January.

What a Disciplined Trader Watches For

A disciplined approach starts with separating the earnings outcome from the expected price reaction. DHR has beaten 7 of the last 8 quarters with an average surprise of 7.3%, so the baseline historical pattern is a beat. But the average five-day drift of -0.2% means the direction afterward is a coin flip in practice. Traders often focus on the gap relative to the 50-day EMA, currently $190.57, and the post-earnings price action relative to that level rather than the headline beat or miss.

Specific numbers to monitor include the immediate next-day percentage change—over the last four reports the range has been wide, from +0.07% to -5.4%—and the five-day drift, which can amplify or reverse the initial move. Intraday volume, relative to the average, and whether RSI, now at 53.8, moves toward overbought or oversold territory can confirm whether the reaction is being bought or sold into. Finally, because DHR trades in the Healthcare/Medical – Diagnostics & Research sector, any change in guidance around diagnostic demand, bioprocessing backlog, or China exposure can matter as much as the EPS print itself.

For a deeper dive into how institutional models and sell-side research interpret these metrics, look at the full institutional verdict on DHR.